A WWOX-binding molecule, transmembrane protein 207, is related to the invasiveness of gastric signet-ring cell carcinoma

Carcinogenesis

Volumn 33, Issue 3, 2012, Pages 548-554

  Takeuchi, Tamotsu ^a   Adachi, Yoshihiro ^c   Nagayama, Tomoko ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN GEL; MATRIGEL; MEMBRANE PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INVASION; CANCER TISSUE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNET RING CARCINOMA; STOMACH CARCINOMA; SUBTRACTIVE HYBRIDIZATION; WESTERN BLOTTING;

EID: 84857963990     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs001     Document Type: Article

References (32)

1. Hyung,W.J. et al. (2002) Early gastric carcinoma with signet ring cell histology. Cancer, 94, 78-83.
2. Piessen,G. et al. (2009) Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann. Surg., 250, 878-887.
3. Kim,J.P. et al. (1994) Prognostic significance of signet ring cell carcinoma of the stomach. Surg. Oncol., 3, 221-227.
4. Yokota,T. et al. (1998) Signet ring cell carcinoma of the stomach: a clinicopathological comparison with the other histological types. Tohoku J. Exp. Med., 186, 121-130.
5. Sugihara,H. et al. (1987) Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch. A. Pathol. Anat. Histopathol., 411, 117-127.
6. Humar,B. et al. (2007) Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res., 67, 2480-2489.
7. Takeichi,M. (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251, 1451-1455.
8. Vleminckx,K. et al. (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107-119.
9. Shimoyama,Y. et al. (1991) Expression of E- and P-cadherin in gastric carcinomas. Cancer Res., 51, 2185-2192.
10. Guilford,P. et al. (1998) E-cadherin germline mutations in familial gastric cancer. Nature, 392, 402-405.
11. Humar,B. et al. (2009) Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci., 100, 1151-1157.
12. Humar,B. et al. (2009) E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res., 69, 2050-2056.
13. Mare,S.D. et al. (2009) WWOX: its genomics, partners, and functions. J. Cell. Biochem., 108, 735-745.
14. Bednarek,A.K. et al. (2001) WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res., 61, 8068-8073.
15. Paige,A.J.W. et al. (2001) WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc. Natl Acad. Sci. USA, 98, 11417-11422.
16. Aqeilan,R.I. et al. (2004) Loss of WWOX expression in gastric carcinoma. Clin. Cancer Res., 10, 3053-3058.
17. Driouch,K. et al. (2002) Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene, 21, 1832-1840.
18. Sekiguchi,M. et al. (1978) Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J. Exp. Med., 48, 61-68.
19. Nakashio,T. et al. (1997) The association of metastasis with the expression of adhesion molecules in cell lines derived from human gastric cancer. Anticancer Res., 17, 293-299.
20. Adachi,Y. et al. (2009) Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer. FEBS Lett., 583, 430-436.
21. Adachi,Y. et al. (2010) T-cadherin modulates tumor-associated molecules in gallbladder cancer cells. Cancer Invest., 28, 120-126.
22. Takeuchi,T. et al. (2006) A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion. Oncogene, 25, 7059-7069.
23. Takeuchi,T. et al. (2003) Down-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanoma. Am. J. Pathol., 163, 1395-1404.
24. Towbin,H. et al. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
25. Takeuchi,T. et al. (2000) Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J. Neurochem., 74, 1489-1497.
26. Bouteille,N. et al. (2009) Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein. Oncogene, 28, 2569-2580.
27. Park,S. et al. (2005) ECop (EGFR-coamplified and overexpressed protein), a novel protein, regulates NF-kappaB transcriptional activity and associated apoptotic response in an IkappaBalpha-dependent manner. Oncogene, 24, 2495-2502.
28. Baras,A. et al. (2009) Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification. Oncogene, 28, 2919-2924.
29. Wu,C.W. et al. (2002) Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Genes Chromosomes Cancer, 35, 219-231.
30. Maeda,N. et al. (2010) Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations. Virchows Arch., 457, 423-432.
31. Aqeilan,R.I. et al. (2004) Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. Cancer Res., 64, 8256-8261.
32. Yasuda,J. et al. (1998) A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J. Virol., 72, 4095-4103.